Use of adjunctive stimulants in adult bipolar depression

Bernardo Dell'Osso, Terence A. Ketter

Research output: Contribution to journalArticlepeer-review

Abstract

Bipolar depression represents a high priority research field, due to its pervasiveness, and high economic and personal (suicidality, impaired function, quality of life) costs, and the limited evidence base to inform therapeutics. Mood stabilizers and second-generation antipsychotics for bipolar depression are commonly only partially effective, and their side-effects may overlap with depressive symptoms such as hypersomnia, daytime drowsiness, fatigue, psychomotor retardation, and weight gain. Moreover, the use of antidepressants in bipolar depression is controversial due to concerns regarding the risks of inefficacy or switching to mood elevation. Stimulants and related compounds such as modafinil and armodafinil have on occasion been used as adjuncts in bipolar depressed patients with encouraging results, but their use is limited by the paucity of systematic evidence of efficacy and safety. The present review aims to provide an updated perspective on the use of stimulants and stimulant-like medications in adult bipolar depression, considering not only recent randomized controlled trials, but also open naturalistic studies, in order to clarify the strengths and limitations of using these agents.

Original languageEnglish
Pages (from-to)55-68
Number of pages14
JournalInternational Journal of Neuropsychopharmacology
Volume16
Issue number1
DOIs
Publication statusPublished - Feb 2013

Keywords

  • Armodafinil
  • bipolar depression
  • methylphenidate
  • modafinil
  • stimulants

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Use of adjunctive stimulants in adult bipolar depression'. Together they form a unique fingerprint.

Cite this